![Mark L. Lewis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Mark L.
Lewis is currently the Executive Chairman at Miroculus, Inc. He previously worked as the Director at Swift Biosciences, Inc. from 2017 to 2021.
He also held the position of General Manager & Vice President at BD Biosciences Clontech.
Actieve functies van Mark L. Lewis
| Bedrijven | Functie | Begin |
|---|---|---|
Miroculus, Inc.
 Miroculus, Inc. Packaged SoftwareTechnology Services Develops software tools for biotechnology company | Voorzitter | 19-04-2022 |
Eerdere bekende functies van Mark L. Lewis
| Bedrijven | Functie | Einde |
|---|---|---|
Swift Biosciences, Inc.
 Swift Biosciences, Inc. BiotechnologyHealth Technology Develops molecular biology reagents | Algemeen Directeur | 01-01-2018 |
BD Biosciences Clontech
 BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
BD Biosciences Clontech
BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Health Technology |
Swift Biosciences, Inc.
Swift Biosciences, Inc. BiotechnologyHealth Technology Develops molecular biology reagents | Health Technology |
Miroculus, Inc.
Miroculus, Inc. Packaged SoftwareTechnology Services Develops software tools for biotechnology company | Technology Services |
